Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey

Radiotherapy and Oncology

Volumn 112, Issue 2, 2014, Pages 155-164

  Grau, Cai ^a   Defourny, Noémie ^b   Malicki, Julian ^c   Dunscombe, Peter ^d   Borras, Josep M ^e   Coffey, Mary ^f   Slotman, Ben ^g   Bogusz, Marta ^h   Gasparotto, Chiara ^b   Lievens, Yolande ⁱ  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b European SocieTy for Radiotherapy and Oncology   (Belgium)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF BARCELONA   (Spain)

^f TRINITY COLLEGE DUBLIN   (Ireland)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Cancer Diagnosis and Treatment Center   (Poland)

ⁱ GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Health economics; Radiotherapy equipment

Indexed keywords

ALBANIA; AUSTRIA; BELARUS; BELGIUM; BULGARIA; COBALT MACHINE; CZECH REPUBLIC; DENMARK; ESTONIA; EUROPE; FINLAND; FRANCE; GERMANY; HOSPITAL DEPARTMENT; HUMAN; HUNGARY; ICELAND; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; IRELAND; ITALY; LINEAR ACCELERATOR; LITHUANIA; LUXEMBOURG; MALTA; MONTENEGRO (REPUBLIC); NETHERLANDS; NORWAY; POLAND; PORTUGAL; QUESTIONNAIRE; RADIOTHERAPY EQUIPMENT; RADIOTHERAPY SIMULATOR; RADIOTHERAPY UNIT; REVIEW; SLOVENIA; SPAIN; STEREOTACTIC DEVICE; SWEDEN; SWITZERLAND; UNITED KINGDOM; DEVICES; ECONOMICS; INFORMATION PROCESSING; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; NEOPLASMS; ONCOLOGY; STATISTICS AND NUMERICAL DATA;

DATA COLLECTION; EUROPE; HUMANS; NEOPLASMS; PARTICLE ACCELERATORS; RADIATION ONCOLOGY; RADIOTHERAPY;

EID: 84910144985     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.08.029     Document Type: Article

References (26)

1. G. Delaney, S. Jacob, C. Featherstone, and M. Barton The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines Cancer 104 2005 1129 1137
2. M.B. Barton, S. Jacob, J. Shafiq, K. Wong, S.R. Thompson, and T.P. Hanna Estimating the demand for radiotherapy from the evidence. A review of changes from 2003 to 2012 Radiother Oncol 112 2014 140 144
3. J.A. Langendijk, P. Lambin, D. De Ruysscher, J. Widder, M. Bos, and M. Verheij Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach Radiother Oncol 107 2013 267 273
4. A.M. Allen, T. Pawlicki, L. Dong, E. Fourkal, M. Buyyounouski, and K. Cengel An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee Radiother Oncol 103 2012 8 11
5. M. Hoyer, H. Roed, Hansen A. Traberg, L. Ohlhuis, J. Petersen, and H Nellemann Phase II study on stereotactic body radiotherapy of colorectal metastases Acta Oncol 45 2006 823 830
6. D. De Ruysscher, M.M. Lodge, B. Jones, M. Brada, A. Munro, and T. Jefferson Charged particles in radiotherapy: a 5-year update of a systematic review Radiother Oncol 103 2012 5 7
7. T. Nishi, Y. Nishimura, T. Shibata, M. Tamura, N. Nishigaito, and M. Okumura Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer Radiother Oncol 106 2013 85 89
8. M. Uhl, B. van Triest, M.J. Eble, D.C. Weber, K. Herfarth, and T.L. De Weese Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial Radiother Oncol 106 2013 215 219
9. S.E. Combs, S. Adeberg, J.O. Dittmar, T. Welzel, S. Rieken, and D. Habermehl Skull base meningiomas: long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT) Radiother Oncol 106 2013 186 191
10. M. Leclerc, P. Maingon, M. Hamoir, C. Dalban, G. Calais, and S. Nuyts A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach Radiother Oncol 106 2013 333 340
11. H.R. Mortensen, K. Jensen, K. Aksglaede, M. Behrens, and C. Grau Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters Radiother Oncol 107 2013 288 294
12. S.M. Bentzen, G. Heeren, B. Cottier, B. Slotman, B. Glimelius, and Y. Lievens Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project Radiother Oncol 75 2005 355 365
13. E. Rosenblatt, J. Izewska, Y. Anacak, Y. Pynda, P. Scalliet, and M. Boniol Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database Lancet Oncol 14 2013 79 86
14. Y. Lievens, and C. Grau Health economics in radiation oncology: introducing the ESTRO-HERO project Radiother Oncol 103 2012 109 112
15. Y. Lievens, M. Coffey, N. Defourny, J. Malicki, P. Dunscombe, J.M. Borras on behalf of the HERO consortium Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey Radiother Oncol 112 2014 178 186
16. Dunscombe P, Grau, C., Defourny, N., Malicki, J., Borras, J.M., Coffey, M., Bogusz, M., Gasparotto, C., Slotman, B., Lievens, Y., on behalf of the HERO consortium. Guidelines for equipment and staffing of radiotherapy facilities in the European countries: Final results of the ESTRO-HERO survey. Radiother Oncol 2014;112:165-77.
17. World Bank Database 2011 [Feb 2014]. Available from: < http://data.worldbank.org/ >.
18. J.A. Hartigan, and M.A. Wong Algorithm AS 136: a K-Means clustering algorithm J R Stat Soc Ser C (Appl Stat) 28 1979 100 108
19. R Core Team. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2013. Available from:< http://www.R-project.org/ >.
20. B.J. Slotman, B. Cottier, S.M. Bentzen, G. Heeren, Y. Lievens, and W. van den Bogaert Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1 Radiother Oncol 75 2005 349 354
21. C. Grau, J.M. Borras, J. Malicki, B. Slotman, P. Dunscombe, and M. Coffey Radiotherapy capacity in Europe Lancet Oncol 14 2013 196 198
22. S. Senan, and B.J. Slotman Outcomes research radiotherapy capacity in Europe-time to even things out? Nat Rev Clin Oncol 10 2013 188 190
23. B.J. Slotman, and P.H. Vos Planning of radiotherapy capacity and productivity Radiother Oncol 106 2013 266 270
24. Y. Lievens, W. van den Bogaert, and K. Kesteloot Activity-based costing: a practical model for cost calculation in radiotherapy Int J Radiat Oncol Biol Phys 57 2003 522 535
25. K. Kesteloot, Y. Lievens, and E. van der Schueren Improved management of radiotherapy departments through accurate cost data Radiother Oncol 55 2000 251 262
26. P. Dunscombe, G. Roberts, and J. Walker The cost of radiotherapy as a function of facility size and hours of operation Br J Radiol 72 1999 598 603